Patent ID: 7560447
Filing Date: 2009-07-14
Classification: A23L,A23V,A61K,A61P

Abstract:
1. A method for treating a person suffering from dementia syndrome or being at risk of developing dementia syndrome, comprising administering to the person a preparation comprising: a) long chain polyunsaturated fatty acid fraction comprising eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA); b) at least two phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine; and c) folic acid, and vitamin B6 wherein the preparation comprises 120-2000 mg per daily dosage of EPA and DHA collectively, of which at least 50 mg of the daily dosage is DHA.